Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPYD | Q12882 | 4/20 | 0.50 |
| ▸ | ATAD2 | Q6PL18 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 2/20 | 0.37 |
| ▸ | MAPT | P10636 | 2/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | THPO | P40225 | 1/20 | 0.37 |
| ▸ | MTOR | P42345 | 1/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.37 |
| ▸ | HBB | P68871 | 1/20 | 0.37 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1050748 | 0.90 | DPYD (0.47) | DPYDATAD2GAAMAPTALDH1A1 | |
| SCHEMBL16585678 | 0.87 | GPR84 (0.46) | DPYDATAD2MAPTALDH1A1TSHR | |
| SCHEMBL3485393 | 0.86 | DPYD (0.53) | DPYDATAD2GAAMAPTALDH1A1 | |
| SCHEMBL887754 | 0.83 | DPYD (0.50) | DPYDATAD2GAAMAPTALDH1A1 | |
| SCHEMBL16586721 | 0.80 | GPR84 (0.43) | DPYDMAPTLMNATSHRSMN1; SMN2 | |
| SCHEMBL16586691 | 0.80 | GPR84 (0.43) | DPYDMAPTLMNATSHRSMN1; SMN2 | |
| SCHEMBL30504798 | 0.80 | DPYD (0.44) | DPYDATAD2GAAMAPTALDH1A1 | |
| SCHEMBL31045516 | 0.79 | DPYD (0.54) | DPYDATAD2GAAMAPTALDH1A1 | |
| SCHEMBL17553298 | 0.79 | DPYD (0.46) | DPYDATAD2GAAMAPTALDH1A1 | |
| SCHEMBL2001029 | 0.79 | DPYD (0.53) | DPYDATAD2GAAMAPTALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 227 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5840867-A | Aptamer analogs specific for biomolecules | GILEAD SCIENCES, INC. (US) | 1998-11-24 | — | — | US | claimed |
| WO-1992014842-A1 | APTAMERS SPECIFIC FOR THROMBIN AND METHODS OF USE | GILEAD SCIENCES, INC. (US) | 1992-09-03 | — | — | WO | claimed |
| US-12146891-B2 | United states systems and methods for fluid and component handling | LABRADOR DIAGNOSTICS LLC (US) | 2024-11-19 | — | — | US | disclosed |
| US-12085583-B2 | Systems and methods for multi-analysis | LABRADOR DIAGNOSTICS LLC (US) | 2024-09-10 | — | — | US | disclosed |
| EP-4220120-A2 | SYSTEMS AND METHODS FOR MULTI-ANALYSIS | Labrador Diagnostics LLC (US) | 2023-08-02 | — | — | EP | disclosed |
| US-11644410-B2 | Systems and methods for sample use maximization | LABRADOR DIAGNOSTICS LLC (US) | 2023-05-09 | — | — | US | disclosed |
| EP-2956754-B1 | SYSTEMS AND METHODS FOR MULTI-ANALYSIS | LABRADOR DIAGNOSTICS LLC (US) | 2023-01-11 | — | — | EP | disclosed |
| US-11524299-B2 | Systems and methods for fluid handling | LABRADOR DIAGNOSTICS LLC (US) | 2022-12-13 | — | — | US | disclosed |
| CN-114994342-A | System and method for multivariate analysis | 赛拉诺斯知识产权有限责任公司 | 2022-09-02 | — | — | CN | disclosed |
| US-20220252503-A1 | SYSTEMS AND METHODS FOR SAMPLE USE MAXIMIZATION | LABRADOR DIAGNOSTICS LLC (US) | 2022-08-11 | — | — | US | disclosed |
| EP-4024029-A2 | SYSTEMS AND METHODS FOR SAMPLE USE MAXIMIZATION | Labrador Diagnostics LLC (US) | 2022-07-06 | — | — | EP | disclosed |
| WO-1996020277-A2 | RECOMBINANT MONOCLONAL ANTI-IDIOTYPE ANTIBODY 3H1 SEQUENCES RELATING TO HUMAN CARCINOEMBRYONIC ANTIGEN | UNIVERSITY OF KENTUCKY (US) | 1996-07-04 | — | — | WO | disclosed |
| WO-1995020317-A1 | METHOD FOR MAKING UNIVERSAL DONOR CELLS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1995-08-03 | — | — | WO | disclosed |
| WO-1995004064-A9 | POLYNUCLEOTIDE DECOYS THAT IHNIBIT MHC-II EXPRESSION AND USES THEREOF | — | 1995-03-09 | — | — | WO | disclosed |
| WO-1995004064-A1 | POLYNUCLEOTIDE DECOYS THAT IHNIBIT MHC-II EXPRESSION AND USES THEREOF | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1995-02-09 | — | — | WO | disclosed |
| EP-0626852-A1 | METHOD FOR MAKING UNIVERSAL DONOR CELLS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1994-12-07 | — | — | EP | disclosed |
| EP-0572529-A1 | APTAMER SPECIFIC FOR BIOMOLECULES AND METHOD OF MAKING | GILEAD SCIENCES, INC. (US) | 1993-12-08 | — | — | EP | disclosed |
| WO-1993014769-A1 | METHOD FOR MAKING UNIVERSAL DONOR CELLS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1993-08-05 | — | — | WO | disclosed |
| WO-1992014842-A1 | APTAMERS SPECIFIC FOR THROMBIN AND METHODS OF USE | GILEAD SCIENCES, INC. (US) | 1992-09-03 | — | — | WO | disclosed |
| WO-1992014843-A1 | APTAMER SPECIFIC FOR BIOMOLECULES AND METHOD OF MAKING | GILEAD SCIENCES, INC. (US) | 1992-09-03 | — | — | WO | disclosed |